Optimization of the separation of NDA-derivatized methylarginines by capillary and microchip electrophoresis

Journal of Laboratory Automation

Volumn 17, Issue 1, 2012, Pages 24-31

  Linz, Thomas H ^a   Snyder, Christa M ^a,b   Lunte, Susan M ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b WITTENBERG UNIVERSITY   (United States)

Author keywords

Capillary electrophoresis; Cardiovascular disease; Methylarginine; Microchip electrophoresis; Naphthalenedialdehyde

Indexed keywords

ARGININE; CAPILLARY ELECTROPHORESIS; CARDIOLOGY; DISEASES; FLUORESCENCE; MICROPROCESSOR CHIPS; NAPHTHALENE; SPACE DIVISION MULTIPLE ACCESS;

ASYMMETRIC DIMETHYLARGININE; CARDIO-VASCULAR DISEASE; LASER INDUCED FLUORESCENCE DETECTION; METHYLARGININE; MICROCHIP ELECTROPHORESIS; NAPHTHALENE-2 ,3-DICARBOXALDEHYDE; NAPHTHALENEDIALDEHYDE; SYMMETRIC DIMETHYLARGININE;

SEPARATION;

2,3 NAPHTHALENEDICARBOXALDEHYDE; 6 N,N' DIMETHYLARGININE; ARGININE; ARGININE DERIVATIVE; MONOMETHYLARGININE; N(G),N(G) DIMETHYLARGININE; UNCLASSIFIED DRUG; 2,3-NAPHTHALENEDICARBOXALDEHYDE; BIOLOGICAL MARKER; DRUG DERIVATIVE; N,N' DIMETHYLARGININE; N,N'-DIMETHYLARGININE; NAPHTHALENE DERIVATIVE;

ANALYTIC METHOD; ARTICLE; CAPILLARY ELECTROPHORESIS; CONCENTRATION (PARAMETERS); DERIVATIZATION; FLUORESCENCE ANALYSIS; LIMIT OF DETECTION; MICROCHIP ANALYSIS; MICROCHIP ELECTROPHORESIS; PROCESS OPTIMIZATION; SEPARATION TECHNIQUE; CARDIOVASCULAR DISEASE; CHEMISTRY; HUMAN; LASER; METHODOLOGY; PROGNOSIS;

ARGININE; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; ELECTROPHORESIS, CAPILLARY; ELECTROPHORESIS, MICROCHIP; HUMANS; LASERS; NAPHTHALENES; PROGNOSIS;

EID: 84864769501     PISSN: 22110682     EISSN: 22110690     Source Type: Journal    
DOI: 10.1177/2211068211424551     Document Type: Article

References (34)

1. American Heart Association. Cardiovascular Disease Statistics. http://www.americanheart.org/presenter.jhtml?identifieri4478.
2. Culotta, E.; Koshland, D. E., Jr. NO News Is Good News. Science. 1992, 258, 1862-1865.
3. Dusting, G. J. Nitric Oxide in Cardiovascular Disorders. J. Vasc. Res. 1995, 32, 143-161.
4. Wennmalm, A. Endothelial Nitric Oxide and Cardiovascular Disease. J. Intern. Med. 1994, 235, 317-327.
5. Marletta, M. A. Nitric Oxide Synthase Structure and Mechanism. J. Biol. Chem. 1993, 268, 12231-12234.
6. Vallance, P. Importance of Asymmetrical Dimethylarginine in Cardiovascular Risk. Lancet. 2001, 358, 2096-2097.
7. Leong, T.; Zylberstein, D.; Graham, I.; Lissner, L.; Ward, D.; Fogarty, J.; Bengtsson, C.; Bjorkelund, C.; Thelle, D. Asymmetric Dimethylarginine Independently Predicts Fatal and Nonfatal Myocardial Infarction and Stroke in Women: 24-Year Follow-up of the Population Study of Women in Gothenburg. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 961-967.
8. Wang, Z.; Tang, W. H. W.; Cho, L.; Brennan, D. M.; Hazen, S. L. Targeted Metabolomic Evaluation of Arginine Methylation and Cardiovascular Risks: Potential Mechanisms beyond Nitric Oxide Synthase Inhibition. Arterioscler. Thromb. Vasc. Biol. 2009, 29, 1383-1391.
9. Goonasekera, C. D. A.; Rees, D. D.; Woolard, P.; Frend, A.; Shah, V.; Dillon, M. J. Nitric Oxide Synthase Inhibitors and Hypertension in Children and Adolescents. J. Hypertens. 1997, 15, 901-909.
10. Duckelmann, C.; Mittermayer, F.; Haider, D. G.; Altenberger, J.; Eichinger, J.; Wolzt, M. Asymmetric Dimethylarginine Enhances Cardiovascular Risk Prediction in Patients with Chronic Heart Failure. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 2037-2042.
11. Duckelmann, C.; Mittermayer, F.; Haider, D. G.; Altenberger, J.; Wolzt, M. Plasma Asymmetric Dimethylarginine and Cardiovascular Events in Patients with Acute Decompensated Heart Failure. Transl. Res. 2008, 152, 24-30.
12. Schnabel, R.; Blankenberg, S.; Lubos, E.; Lackner, K. J.; Rupprecht, H. J.; Espinola-Klein, C.; Jachmann, N.; Post, F.; Peetz, D.; Bickel, C.; Cambien, F.; Tiret, L.; Munzel, T. Asymmetric Dimethylarginine and the Risk of Cardiovascular Events and Death in Patients with Coronary Artery Disease: Results from the AtheroGene Study. Circ. Res. 2005, 97, e53-59.
13. Miyazaki, H.; Matsuoka, H.; Cooke, J. P.; Usui, M.; Ueda, S.; Okuda, S.; Imaizumi, T. Endogenous Nitric Oxide Synthase Inhibitor: A Novel Marker of Atherosclerosis. Circulation. 1999, 99, 1141-1146.
14. Lee, L.; Webb, R. C. Endothelium-Dependent Relaxation and L-Arginine Metabolism in Genetic Hypertension. Hypertension. 1992, 19, 435-441.
15. Zeller, M.; Korandji, C.; Guilland, J. C.; Sicard, P.; Vergely, C.; Lorgis, L.; Beer, J. C.; Duvillard, L.; Lagrost, A. C.; Moreau, D.; Gambert, P.; Cottin, Y.; Rochette, L. Impact of Asymmetric Dimethylarginine on Mortality after Acute Myocardial Infarction. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 954-960.
16. Zoccali, C.; Bode-Boger, S. M.; Mallamaci, F.; Benedetto, F. A.; Tripepi, G.; Malatino, L. S.; Cataliotti, A.; Bellanuova, I.; Fermo, I.; Frolich, J. C.; Boger, R. H. Plasma Concentration of Asymmetrical Dimethylarginine and Mortality in Patients with End-Satge Renal Disease: A Prospective Study. Lancet. 2001, 358, 2113-2117.
17. Fleck, C.; Janz, A.; Schweitzer, F.; Karge, E.; Schwertfeger, M.; Stein, G. Serum Concentrations of Asymmetric (ADMA) Dimethylarginine and Symmetric (SDMA) Dimethylarginine in Renal Failure Patients. Kidney Int. 2001, 59, S14-S18.
18. Tran, C. T. L.; Leiper, J. M.; Vallance, P. The DDAH/ADMA/ NOS Pathway. Atheroscler. Suppl. 2003, 4, 33-40.
19. Zakrzewicz, D.; Eickelberg, O. From Arginine Methylation to ADMA: A Novel Mechanism with Therapeutic Potential in Chronic Lung Diseases. BMC Pulm. Med. 2009, 9, 5.
20. Chirinos, J. A.; David, R.; Bralley, J. A.; Zea-Diaz, H.; Munoz-Atahualpa, E.; Corrales-Medina, F.; Cuba-Bustinza, C.; Chirinos-Pacheco, J.; Medina-Lezama, J. Endogenous Nitric Oxide Synthase Inhibitors, Arterial Hemodynamics, and Subclinical Vascular Disease: The PREVENCION Study. Hypertension. 2008, 52, 1051-1059.
21. Bulau, P.; Zakrzewicz, D.; Kitowska, K.; Leiper, J.; Gunther, A.; Grimminger, F.; Eickelberg, O. Analysis of Methylarginine Metabolism in the Cardiovascular System Identifies the Lung as a Major Source of ADMA. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292, L18-L24.
22. Ajtay, Z.; Scalera, F.; Cziraki, A.; Horvath, I.; Papp, L.; Sulyok, E.; Szabo, C.; Martens-Lobenhoffer, J.; Awiszus, F.; Bode-Boger, S. M. Stent Placement in Patients with Coronary Heart Disease Decreases Plasma Levels of the Endogenous Nitric Oxide Synthase Inhibitor ADMA. Int. J. Mol. Med. 2009, 23, 651-657.
23. Bruin, G. J. M., Recent Developments in Electrochemically Driven Analysis on Microfabricated Devices. Electrophoresis. 2000, 21, 3931-3951.
24. Desiderio, C.; Rossetti, D. V.; Messana, I.; Giardina, B.; Castagnola, M. Analysis of Arginine and Methylated Metabolites in Human Plasma by Field Amplified Sample Injection Capillary Electrophoresis Tandem Mass Spectrometry. Electrophoresis. 2010, 31, 1894-1902.
25. Zinellu, A.; Sotgia, S.; Scanu, B.; Formato, M.; Deiana, L.; Carru, C. Assessment of Protein-Incorporated Arginine Methylation in Biological Specimens by CZE UV-Detection. Electrophoresis. 2007, 28, 4452-4458.
26. Trapp, G.; Sydow, K.; Dulay, M. T.; Chou, T.; Cooke, J. P.; Zare, R. N. Capillary Electrophoretic and Micellar Electrokinetic Separations of Asymmetric Dimethyl-L-Arginine and Structurally Related Amino Acids: Quantitation in Human Plasma. J. Sep. Sci. 2004, 27, 1483-1490.
27. Causse, E.; Siri, N.; Arnal, J. F.; Bayle, C.; Malatray, P.; Valdiguie, P.; Salvayre, R.; Couderc, F. Determination of Asymmetric Dimethylarginine by Capillary Electrophoresis-Laser Induced Fluorescence. J. Chromatogr. B. 2000, 741, 77-83.
28. Lunte, S. M.; Wong, O. S. Precolumn Derivatization with Naphthalenedialdehyde/Cyanide for Fluorescence, Chemiluminescence or Electrochemical Detection of Primary Amines and Peptides. Curr. Sep. 1990, 10, 19-25.
29. Lunte, S. M.; Wong, O. S. Naphthalenedialdehyde-Cyanide: A Versatile Fluorogenic Reagent for the LC Analysis of Peptides and Other Primary Amines. LC-GC. 1989, 7, 908-910, 912, 914, 916.
30. Huynh, B. H.; Fogarty, B. A.; Nandi, P.; Lunte, S. M. A Micochip Electrophoresis Device with On-line Microdialysis Sampling and On-chip Sample Derivatization by Naphthalene 2,3-dicarboxaldehyde/2-mercaptoethanol for Amino Acid and Peptide Analysis. J. Pharm. Biomed. Anal. 2006, 42, 529-534.
31. Coltro, W. K. T.; Lunte, S. M.; Carrilho, E. Comparison of the Analytical Performance of Electrophoresis Microchannels Fabricated in PDMS, Glass, and Polyester-Toner. Electrophoresis. 2008, 29, 4928-4937.
32. Male, K. B.; Luong, J. H. Derivatization, Stabilization and Detection of Biogenic Amines by Cyclodextrin-Modified Capillary Electrophoresis-Laser-Induced Fluorescence Detection. J. Chromatogr. A. 2001, 926, 309-317.
33. Zia, V.; Rajewski, R. A.; Stella, V. J. Effect of Cyclodextrin Charge on Complexation of Neutral and Charged Substrates: Comparison of (SBE)7M-β-CD to HP-β-CD. Pharm. Res. 2001, 18, 667-673.
34. Petersen, N. J.; Nikolajsen, R. P. H.; Mogensen, K. B.; Kutter, J. P. Effect of Joule Heating on Efficiency and Performance for Microchip-Based and Capillary-Based Electrophoretic Separation Systems: A Closer Look. Electrophoresis. 2004, 25, 253-269.